Four-year outcomes from a prospective phase II clinical trial of moderately hypofractionated proton therapy for localized prostate cancer

This study was performed to determine the clinical and patient-reported outcomes for patients with PC treated with HFPT.

Source: International Journal of Radiation Oncology * Biology * Physics - June 10, 2019 Category: Radiology Authors: Amardeep S. Grewal, Caitlin Schonewolf, Eun Jeong Min, Hann-Hsiang Chao, Stefan Both, Sarah Lam, Susan Mazzoni, Justin Bekelman, John Christodouleas, Neha Vapiwala Source Type: research